|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 43/00 | |
| A61K 45/06 | |||
| A61K 31/4184 | |||
| A61K 31/4439 | |||
| A61K 31/4745 | |||
| A61K 31/496 | |||
| A61K 31/506 | |||
| A61K 31/519 | |||
| A61K 31/53 | |||
| A61K 31/5377 | |||
| A61P 35/00 |
| (11) | Number of the document | 2976106 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14715440.5 |
| Date of filing the European patent application | 2014-03-19 | |
| (97) | Date of publication of the European application | 2016-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/059975 |
| Date | 2014-03-19 |
| (87) | Number | WO 2014/147573 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361804056 P | 2013-03-21 | US |
| (72) |
CAPONIGRO, Giordano, US
STUART, Darrin, US
DE PARSEVAL, Laure, CH
|
| (73) |
Array BioPharma Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
|
| (54) | COMBINATION THERAPY COMPRISING A B-RAF INHIBITOR AND A SECOND INHIBITOR |
| COMBINATION THERAPY COMPRISING A B-RAF INHIBITOR AND A SECOND INHIBITOR |